Elutia Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Elutia has 3 disclosed suppliers and 6 disclosed customers in SEC filings.
Elutia Inc.
0.84
+0.02 · +2.89%
post 0.86 +2.74%
SentenceAt present, Berkeley is our single source of supply for SimpliDerm.
ELUT 10-Kaccession 0001104659-26-027664
SentenceWe obtain some of our raw materials from a limited group of suppliers and, for reasons of quality assurance, cost-effectiveness, availability or constraints resulting from regulatory requirements, we rely on a single supplier, Cook, to source the SIS ECM biomaterial used to manufacture our Cardiovascular products.
ELUT 10-Kaccession 0001104659-26-027664
SentenceAlong with this license agreement, Elutia entered into a supply agreement whereby Cook would be the exclusive supplier to Elutia of licensed porcine tissue.
ELUT 10-Kaccession 0001104659-26-027664
SentenceOn September 8, 2025, Elutia executed an Asset Purchase Agreement (the "APA") with Boston Scientific Corporation ("BSC"), a Delaware corporation, and Cardiac Pacemakers Inc. ("CPI"), a Minnesota corporation (collectively with BSC, the " CIED Buyers").
SentenceIn particular, the complaint alleges that Medtronic did not honor its contractual obligations to defend and indemnify the Company for over 100 lawsuits against the Company alleging claims arising from the use of FiberCel products distributed by Medtronic and that Medtronic concealed and misrepresented an insurance policy potentially applicable to those FiberCel-related lawsuits.
SentenceOn September 8, 2025, Elutia executed an Asset Purchase Agreement (the "APA") with Boston Scientific Corporation ("BSC"), a Delaware corporation, and Cardiac Pacemakers Inc. ("CPI"), a Minnesota corporation (collectively with BSC, the " CIED Buyers").
ELUT 10-Kaccession 0001104659-26-027664
SentenceIn April 2023, we entered into an exclusive distribution agreement with LeMaitre Vascular for these products in the United States.
ELUT 10-Kaccession 0001104659-26-027664
SentenceFrom March 2023 through October 2025, SimpliDerm was also distributed under a non-exclusive agreement with Sientra and its successor, Tiger Aesthetics Medical ("Tiger"), which was terminated in October 2025.
ELUT 10-Kaccession 0001104659-26-027664
SentenceFrom March 2023 through October 2025, SimpliDerm was also distributed under a non-exclusive agreement with Sientra and its successor, Tiger Aesthetics Medical ("Tiger"), which was terminated in October 2025.
ELUT 10-Kaccession 0001104659-26-027664
Linked news
Expected move
No implied move.